002004 华邦健康
2025/06 - 中期2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)4.071-3.0762.9774.2716.767
总资产报酬率 ROA (%)1.314-0.9940.9951.4432.292
投入资产回报率 ROIC (%)1.973-1.4931.4932.1283.272

边际利润分析
销售毛利率 (%)36.28334.12739.11440.49438.201
营业利润率 (%)11.214-1.0927.99112.43210.728
息税前利润/营业总收入 (%)13.4660.9399.68713.83113.838
净利润/营业总收入 (%)9.249-2.9375.8388.5197.402

收益指标分析
经营活动净收益/利润总额(%)85.642-564.840128.369103.23881.532
价值变动净收益/利润总额(%)6.996105.2800.97726.90924.080
营业外收支净额/利润总额(%)3.51320.605-3.824-1.375-4.089

偿债能力分析
流动比率 (X)1.2301.0831.0711.0401.081
速动比率 (X)0.9990.8660.8190.8120.870
资产负债率 (%)46.16747.46046.02644.88347.340
带息债务/全部投入资本 (%)47.56649.25147.49945.97648.261
股东权益/带息债务 (%)103.67796.637104.097110.721101.104
股东权益/负债合计 (%)71.20566.80371.45275.62171.074
利息保障倍数 (X)7.3040.4064.8678.8213.919

营运能力分析
应收账款周转天数 (天)68.59256.66953.12058.40862.200
存货周转天数 (天)105.152115.442132.847112.879102.001